Umbilical moxibustion for patients with idiopathic pulmonary fibrosis complicated with gastroesophageal reflux of lung-spleen deficiency.
10.13703/j.0255-2930.2019.03.004
- Author:
Bin LI
1
;
Yi ZHANG
1
;
Qin-Mei YANG
1
Author Information
1. the First Affiliated Hospital of Henan University of CM, Zhengzhou 450000, China.
- Publication Type:Journal Article
- Keywords:
Point CV8 (Shenque);
gastroesophageal reflux;
idiopathic pulmonary interstitial fibrosis;
umbilical moxibustion
- MeSH:
Gastroesophageal Reflux;
Humans;
Idiopathic Pulmonary Fibrosis;
therapy;
Moxibustion;
Qi;
Quality of Life;
Spleen
- From:
Chinese Acupuncture & Moxibustion
2019;39(3):241-245
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the clinical efficacy of umbilical moxibustion in the treatment of patients with idiopathic pulmonary interstitial fibrosis complicated with gastroesophageal reflux of lung-spleen deficiency.
METHODS:A total of 116 patients with idiopathic pulmonary fibrosis complicated with gastroesophageal reflux of lung spleen-deficiency were randomized into an observation group (58 cases) and a control group (58 cases). In the control group, the routine treatment was applied; in the observation group, on the base of the treatment as the control group, the umbilical moxibustion was used. The treatment was given 2 times a week, 2 h each time for 12 weeks, and followed up for 12 weeks after treatment. The composite physiological indicators (CPI), TCM syndrome scores, the St. George respiratory questionnaire score (SGRQ) and 6-minute walk test (6MWT) were compared before and after treatment in the two groups.
RESULTS:The improvement of the TCM syndrome scores (cough, post-activity shortness of breath, fatigue, heartburn, acid reflux), CPI score and 6MWT in the observation group was better than those in the control group (all <0.05). There was no significant difference in the scores of SGRQ scale between the two groups after treatment (>0.05). There was no significant difference in the scores of CPI scores and syndromes (cough and fatigue) between the two groups at 12 weeks after treatment (all >0.05). The 6MWT, SGRQ scale scores and syndrome scores (post-activity shortness of breath, acid reflux, heartburn) were better than those in the control group in the follow up (all <0.05).
CONCLUSION:Umbilical moxibustion can improve the ventilation and diffusion function of lung in patients with idiopathic pulmonary fibrosis and gastroesophageal reflux of lung-spleen deficiency, reduce clinical symptoms and improve patients' quality of life and activity endurance. And it has long-term effect.
